Novocure secures Japan insurance reimbursement for Optune Lua in advanced lung cancer treatment
Novocure receives reimbursement approval from Japan’s Ministry of Health, Labour and Welfare of Japan for Optune Lua, enabling insured access for advanced NSCLC patients using Tumour Treating Fields therapy.
Lab Equipment | 05/03/2026 | By News Bureau | 125
Astellas-Vir Partnership Advances Dual-Masked T-Cell Engager for Advanced Prostate Cancer
Astellas Pharma Inc. and Vir Biotechnology, Inc. have entered into a global strategic collaboration to develop and commercialize VIR-5500, an investigational PRO-XTEN dual-masked CD3 T-cell engager (TCE) targeting prostate-specific membrane antigen (PSMA) for the treatment of prostate cancer.
Lab Equipment | 25/02/2026 | By Darshana | 135
NOVOS Reports Positive Clinical Trial Results Showing Improvements in Vascular Aging Markers
A randomised clinical trial led by the University of Surrey found that NOVOS Core significantly improved endothelial function, arterial flexibility and systolic blood pressure in adults over 40 compared with placebo.
Lab Equipment | 20/02/2026 | By News Bureau | 406
Hologic's Aptima HPV Assay Receives US FDA Approval for Primary Cervical Cancer Screening
US FDA approves Hologic’s mRNA-based Aptima HPV assay for clinician-collected primary screening, expanding cervical cancer testing options and enhancing early detection of high-risk infections.
Lab Equipment | 07/02/2026 | By News Bureau | 156
Nanox Secures US FDA Clearance for TAP2D Image Enhancement Software for ARC Systems
FDA grants 510(k) clearance to Nanox’s cloud-enabled TAP2D software, enabling 2D image generation from a single tomosynthesis scan and advancing its strategy to position ARC systems as primary diagnostic solutions.
Lab Equipment | 05/02/2026 | By News Bureau | 294
OneSource Reports INR 47 Crore Net Loss in Q3 FY26 as Revenue Falls 26 Percent
OneSource Specialty Pharma reported a weak performance in the third quarter of FY26, posting a net loss of INR 47 crore for the quarter ended December 31, 2025. The company’s revenue declined 26 percent year on year to INR 290 crore, largely due to delays in converting a key service agreement into a commercial supply contract.
Lab Equipment | 27/01/2026 | By Darshana | 179
Bridge to Life Secures FDA De Novo Clearance for VitaSmart HOPE System in Liver Transplantation
Bridge to Life has received FDA De Novo clearance for its VitaSmart HOPE System, creating a new regulatory pathway for hypothermic oxygenated perfusion in US liver transplantation.
Lab Equipment | 21/01/2026 | By News Bureau | 283
GCCL and OPIS Forge Strategic Alliance to Expand Global Clinical Trial Services
GCCL, a South Korea-based leader in clinical trial sample analysis, and OPIS, a global full-service contract research organization (CRO), have entered into a Memorandum of Understanding (MoU) to deepen collaboration and enhance their footprint in the global clinical trial market.
Lab Equipment | 16/01/2026 | By Darshana | 147
Sky Labs's Ring-Type Blood Pressure Monitor Secures CE-MDR Certification in Europe
Certification clears Cart Platform for European market entry, validating cuffless blood pressure monitoring technology and supporting global expansion plans.
Lab Equipment | 08/01/2026 | By News Bureau | 400
StimLabs Secures FDA 510(k) Clearance for Umbilical Cord-Derived Wound Care Sheet Device
StimLabs, a regenerative medicine company focused on advancing wound care solutions, has received 510(k) clearance from the US Food and Drug Administration (FDA) for Theracor, the first human umbilical cord-derived medical device available in sheet form.
Lab Equipment | 01/01/2026 | By Darshana | 246
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy